Normal function · from ai-gene-review (Q14145, commit 79fe13b38970) · AI-generated, not KB evidence

KEAP1 (Kelch-like ECH-associated protein 1) is a cysteine-rich BTB-BACK-Kelch protein that functions as the principal substrate adaptor of the BCR(KEAP1) E3 ubiquitin ligase complex (CUL3-RBX1-KEAP1). In its homodimeric form, KEAP1 binds the Neh2 domain of NRF2 (NFE2L2) via two degron motifs (ETGE and DLG) and targets NRF2 for polyubiquitination and proteasomal degradation under basal conditions. KEAP1 contains reactive cysteine residues (especially Cys151, Cys273, Cys288) that act as sensors for electrophiles and oxidative stress. Upon covalent modification of these cysteines by electrophilic compounds (sulforaphane, itaconate, etc.) or reactive oxygen species, the E3 ligase activity is inhibited, allowing NRF2 to accumulate and translocate to the nucleus to activate cytoprotective genes via antioxidant response elements (AREs). KEAP1 is primarily cytoplasmic and is also regulated by autophagy through interaction with SQSTM1/p62, which sequesters KEAP1 in inclusion bodies. Loss-of-function mutations in KEAP1 are frequent in lung cancer and lead to constitutive NRF2 activation, promoting tumor growth and chemoresistance.

KEAP1 functions as the substrate-recognition component (substrate adaptor) of the CUL3-RBX1 E3 ubiquitin ligase complex. It binds CUL3 via its BTB domain and recruits substrates (primarily NRF2) via its Kelch domain.
KEAP1 inhibits NRF2 (NFE2L2), a master transcription factor regulating antioxidant and cytoprotective gene expression. Under basal conditions, KEAP1 targets NRF2 for ubiquitination and proteasomal degradation, thereby inhibiting NRF2-mediated transcription.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Large Cell Neuroendocrine Carcinoma somatic driver somatic
mechanism: STK11 and KEAP1 Biallelic Inactivation
KRAS G12C-Mutant Non-Small Cell Lung Cancer untyped
Co-occurring Inactivation
Non-Small Cell Lung Cancer untyped
Loss-of-function Mutations

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.